呼吸管理機器市場 : 2028年までの世界予測

出版:MarketsandMarkets(マーケッツアンドマーケッツ) 出版年月:2023年9月

Respiratory Care Devices Market – Global Forecast to 2028

呼吸管理機器市場 : 製品 [治療薬 (CPAP、人工呼吸器、ネブライザー、吸入器)、パルスオキシメーター、肺活量計]、適応症、エンドユーザー、主要な関係者と期待、アンメットニーズ、購入基準、償還 – 2028年までの世界予測
Respiratory Care Devices Market by Product (Therapeutic (CPAP, Ventilator, Nebulizer, Inhaler), Pulse Oximeter, Spirometer), Indication, End User, Key stakeholders & Expectations, Unmet needs, Buying Criteria, Reimbursement – Global Forecast to 2028

ページ数449
図表数617
種別英文調査報告書
価格

お問合せ・ご注文  価格・納期について

Report Overview

The global respiratory care devices market is projected to reach USD 31.8 billion by 2028 from USD 21.8 billion in 2023, at a CAGR of 7.8%. Rising prevalence of respiratory diseases as a result of the rapid growth in the global geriatric population will drive the market growth.

呼吸管理機器市場 : 2028年までの世界予測

COPD and asthma are the most prevalent respiratory disorders across the globe. As per the WHO, COPD is the third leading cause of death worldwide, causing 3.2 million deaths in 2019. More than 80% of these deaths have occurred in low and middle-income countries. Over 380 million people globally are anticipated to have COPD. Largely undiagnosed COPD patients are high in regions and countries, such as China, India, Brazil, and Eastern Europe. The cost incurred to healthcare systems for COPD across the globe is nearly USD 50 billion annually. Some of the major causes of COPD are long-term asthma and prolonged exposure to tobacco smoke, indoor & outdoor air pollution, and occupational fumes & dust. Other comorbid chronic conditions, including cardiovascular disease, musculoskeletal impairment, and diabetes mellitus, are related to COPD. These conditions may also impact the health status of patients, as well as interfere with COPD management.

呼吸管理機器市場 : 2028年までの世界予測 ecosystem

“The ventilators segment holds the major share of the therapeutic respiratory care devices market”
The therapeutic respiratory care devices market is segmented into ventilators, positive airway pressure (PAP) devices, humidifiers, nebulizers, oxygen concentrators, reusable resuscitators, inhalers, masks, nitric oxide delivery units, and oxygen hoods. In 2022, the ventilators segment holds the major share of the therapeutic respiratory care devices market. A large share of the ventilator segment can be attributed to the rising number of intensive care beds equipped with ventilators, increasing ICU admission and re-admissions in developed countries, and the favorable reimbursement scenario.

“The COPD segment holds the major share of the respiratory care devices market”
By disease indiation the respiratory care devices market is segmented into chronic obstructive pulmonary disease (COPD), asthma, sleep apnea, infectious diseases, and other disease indications. The COPD segment holds the major share of the respiratory care devices market. A large share of the COPD segment can be attributed to the tobacco smoking, genetic disorders, and the increasing geriatric population. The high prevalence of COPD and the growing number of deaths caused by COPD are expected to drive the demand for respiratory care devices during the forecast period.


“The hospitals segment holds the major share of the respiratory care devices market”
By end user the respiratory care devices market is segmented into hospitals, home care settings, ambulatory care centers (ACCs), and other end users. The hospitals segment holds the major share of the respiratory care devices market. A large share of the hospitals segment can be attributed to the financial capabilities of hospitals to purchase expensive equipment and the availability of trained professionals in hospitals to operate respiratory care devices. Additionally, the trend of economic expansion and government focus on broader welfare policies has led to the growth of the healthcare sector in emerging economies.

呼吸管理機器市場 : 2028年までの世界予測 region

“Asia Pacific will grow at highest CAGR during the forecast period”
In 2022, Asia Pacific will grow at highest CAGR during the forecast period. The high growth in this market can majorly be attributed to the to high-growth markets such as Japan, China, India, South Korea, Taiwan, Australia, and Singapore. In these countries, the rising geriatric population, growing per capita income, increasing investments in the healthcare industry by key market players.

“Improved profitability & mobility and enhanced remote moitoring–unmet needs in the respiratory care devices market”
• Many respiratory patients need oxygen therapy but require more lightweight, compact devices for increased mobility. Currently available portable devices may not fully meet this need.
• There’s a growing demand for remote patient monitoring to reduce hospital admissions and improve patient outcomes. However, existing solutions may lack full integration or real-time data transmission.
The break-up of the profile of primary participants in the the respiratory care devices market (Supply Side):
• By Company Type: Tier 1 – 35%, Tier 2 – 40%, and Tier 3 – 25%
• By Designation: C Level – 20%, Director Level – 35%, Others-45%
• By Region: North America – 30%, Europe – 27%, Asia Pacific – 25%, Middle East – 10%, and Latin America – 8%

The break-up of the profile of primary participants in the the respiratory care devices market (Demand Side):
• By End User: Hospitals- 47%, Home Care- 33%, Others-20%
• By Designation: Doctors-35%, Diagnostic Centre Lab Heads-27%, Hospital Directors & Managers-22%, Others-16%
• By Region: North America-34%, Europe-22%, Asia Pacific-20%, Latin America-16%, Middle East & Africa-8%

The prominent players in the the respiratory care devices market include Koninklijke Philips N.V. (Netherlands), General Electric Healthcare (US), ResMed Inc. (US), Fisher & Paykel Healthcare Corporation Limited (New Zealand), Medtronic plc (Ireland), Masimo Corporation (US), Drägerwerk AG & Co.(Germany), Getinge AB (Sweden), Nihon Kohden Corporation (US), Vyaire Medical (US), Hill-Rom, Inc. (US), AdaptHealth LLC (US), Rotech Healthcare, Inc. (US), Teleflex Incorporated(Japan), Air Liquide (France), Invacare Corporation (US), ICU Medical Inc. (US), Hamilton Medical AG (Switzerland), Apex Medical Corporation (Taiwan), Apex Medical Corporation (US), HUM GmbH (Germany), Nonin Medical (US), Allied Healthcare Products, Inc. (US), Drive DeVilbiss Healthcare (US), OMRON Healthcare, Inc. (Japan).


Research Coverage:
The report analyzes the respiratory care devices market and aims at estimating the market size and future growth potential of this market based on various segments such as product, disease indication, end user and region. The report also includes a product portfolio matrix of various respiratory care devices available in the market. The report also provides a competitive analysis of the key players in this market, along with their company profiles, product, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall respiratory care devices market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and to plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.

This report provides insights into the following pointers:
• Analysis of key drivers (Rising Prevalence of Respiratory Diseases, Increasing incidence rate of preterm births, Outbreak of infectious diseases affecting the respiratory system, Underpenetrated markets in sleep and COPD, Focus on improving patient outcomes, Rising R&D investments resulting in technologically advanced devices), restraints (Unfavorable reimbursement scenario, Availability of low-cost products from local manufacturers, High cost of CPAP machines), opportunities (Growing demand for home care therapeutic devices, High growth in developing countries, Point-of-care Diagnostics, Growing awareness about the ill-effects of untreated sleep apnea), and challenges (Low awareness and a large underdiagnosed and undertreated population, Harmful effects of certain devices on neonates)
• Product Development/Innovation: Detailed insights on upcoming technologies, research & development activities, and new product launches in the respiratory care devices market
• Market Development: Comprehensive information on the lucrative emerging markets by product, disease indication, end user and region.
• Market Diversification: Exhaustive information about new products or product enhancements, growing geographies, recent developments, and investments in the global respiratory care devices market.
• Competitive Assessment: In-depth assessment of market shares, growth strategies, product offerings, competitive leadership mapping, and capabilities of leading players like Koninklijke Philips N.V. (Netherlands), General Electric Healthcare (US), ResMed Inc. (US), Fisher & Paykel Healthcare Corporation Limited (New Zealand), and Medtronic plc (Ireland) in the global respiratory care devices market. 

Table of Contents

1            INTRODUCTION            55

1.1         STUDY OBJECTIVES      55

1.2         MARKET DEFINITION   55

1.2.1      INCLUSIONS AND EXCLUSIONS 55

1.3         MARKET SCOPE             56

1.3.1      MARKETS COVERED     56

FIGURE 1           RESPIRATORY CARE DEVICES MARKET SEGMENTATION              56

FIGURE 2           RESPIRATORY CARE DEVICES MARKET, BY REGION       57

1.3.2      YEARS CONSIDERED     57

1.4         CURRENCY CONSIDERED          58

TABLE 1             ANNUAL AVERAGE EXCHANGE RATE FOR CURRENCY CONVERSION, 2018–2022            58

1.5         STAKEHOLDERS            58

1.6         LIMITATIONS   58

1.7         SUMMARY OF CHANGES            58

1.8         RECESSION IMPACT      59

2            RESEARCH METHODOLOGY     60

2.1         RESEARCH DATA           60

FIGURE 3           RESEARCH DESIGN       60

2.1.1      SECONDARY DATA       61

2.1.1.1   Key data from secondary sources     62

2.1.2      PRIMARY DATA 62

FIGURE 4           PRIMARY SOURCES       63

2.1.2.1   Key data from primary sources         64

2.1.2.2   Key industry insights          64

FIGURE 5           BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 65

FIGURE 6           BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 65

FIGURE 7           BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION            66

2.2         MARKET SIZE ESTIMATION       66

FIGURE 8           SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS          67

FIGURE 9           REVENUE SHARE ANALYSIS ILLUSTRATION: KONINKLIJKE PHILIPS N.V.     67

FIGURE 10         SUPPLY-SIDE MARKET ESTIMATION: RESPIRATORY CARE DEVICES MARKET (2022)            68

FIGURE 11         DEMAND-SIDE MARKET ESTIMATION: VENTILATORS MARKET (2022) 69

FIGURE 12         TOTAL MARKET SIZE ESTIMATION: RESPIRATORY CARE DEVICES MARKET         70

FIGURE 13         CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES (2023–2028) 71

FIGURE 14         CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS   72

FIGURE 15         TOP-DOWN APPROACH             73

2.3         MARKET BREAKDOWN AND DATA TRIANGULATION    73

FIGURE 16         MARKET DATA TRIANGULATION METHODOLOGY       73

2.4         STUDY ASSUMPTIONS  74

2.4.1      MARKET SHARE ASSUMPTIONS 74

2.4.2      RESEARCH ASSUMPTIONS         74

2.5         RISK ASSESSMENT         74

TABLE 2             RESPIRATORY CARE DEVICES MARKET: RISK ASSESSMENT ANALYSIS          74

2.6         RESEARCH LIMITATIONS           74

2.7         RECESSION IMPACT ANALYSIS 75

3            EXECUTIVE SUMMARY 76

FIGURE 17         RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2023 VS. 2028 (USD MILLION)     76

FIGURE 18         RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2023 VS. 2028 (USD MILLION)        77

FIGURE 19         RESPIRATORY CARE DEVICES MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)     78

FIGURE 20         RESPIRATORY CARE DEVICES MARKET: GEOGRAPHICAL SNAPSHOT        79

4            PREMIUM INSIGHTS      80

4.1         RESPIRATORY CARE DEVICES MARKET OVERVIEW        80

FIGURE 21         HIGH TOBACCO CONSUMPTION TO BOOST MARKET GROWTH THROUGHOUT FORECAST PERIOD   80

4.2         NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY TYPE (2022)   81

FIGURE 22         THERAPEUTIC RESPIRATORY CARE DEVICES ACCOUNTED FOR LARGEST MARKET SHARE IN 2022  81

4.3         RESPIRATORY CARE DEVICES MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES           82

FIGURE 23         INDIA TO DISPLAY HIGHEST CAGR DURING FORECAST PERIOD              82

4.4         RESPIRATORY CARE DEVICES MARKET: REGIONAL MIX 82

FIGURE 24         NORTH AMERICA TO CONTINUE TO DOMINATE MARKET THROUGHOUT FORECAST PERIOD       82

4.5         RESPIRATORY CARE DEVICES MARKET: DEVELOPED VS. EMERGING ECONOMIES     83

FIGURE 25         EMERGING ECONOMIES TO REGISTER HIGHER CAGRS DURING FORECAST PERIOD     83

5            MARKET OVERVIEW     84

5.1         INTRODUCTION            84

5.2         MARKET DYNAMICS     84

FIGURE 26        RESPIRATORY CARE DEVICES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES AND CHALLENGES    84

5.2.1      DRIVERS            85

5.2.1.1   Rising prevalence of respiratory diseases        85

5.2.1.1.1 Rapid growth in global geriatric population    86

FIGURE 27         GLOBAL GERIATRIC POPULATION, BY REGION 86

5.2.1.1.2 Urbanization and growing pollution levels     86

FIGURE 28         ANNUAL DATA OF DEATHS CAUSED BY HOUSEHOLD AND AMBIENT AIR POLLUTION, BY DISEASE 87

5.2.1.1.3 Growing tobacco consumption         87

TABLE 3             REGION-WISE DATA ON LIFESTYLE DISEASES   87

5.2.1.1.4 Increased adoption of sedentary lifestyles      88

5.2.1.2   Surging incidence rate of preterm births        88

TABLE 4             TOP 10 COUNTRIES WITH HIGHEST NUMBER OF PRETERM BIRTHS 88

TABLE 5             TOP 10 COUNTRIES WITH HIGHEST RATES OF PRETERM BIRTH PER 100 LIVE BIRTHS      89

5.2.1.3   Growing outbreaks of infectious diseases affecting respiratory systems    89

5.2.1.4   Rising population with sleep disorders           89

5.2.1.5   Improved patient outcomes using respiratory care devices         90

5.2.1.6   Surging R&D investments for technological advancement of medical devices              90

TABLE 6             PRODUCT LAUNCHES  91

5.2.2      RESTRAINTS     91

5.2.2.1   Unfavorable reimbursement scenario for respiratory care diagnostics       91

5.2.2.2   Availability of low-cost products from local manufacturers         91

5.2.2.3   High cost of CPAP machines           92

5.2.3      OPPORTUNITIES           92

5.2.3.1   Growing demand for home care therapeutic devices    92

5.2.3.2   Market growth opportunities in Asia Pacific and Latin America 93

5.2.3.3   Increasing preference for self-testing             93

5.2.3.4   Growing awareness about ill effects of untreated sleep apnea     94

TABLE 7             INITIATIVES TO PROMOTE AWARENESS ABOUT UNTREATED SLEEP APNEA   94

5.2.4      CHALLENGES   95

5.2.4.1   Low awareness and lack of diagnosis of respiratory diseases       95

5.2.4.2   Harmful effects of certain respiratory care devices on neonates  95

5.2.4.3   Lack of patient compliance with CPAP therapy           96

5.3         INDUSTRY TRENDS       96

5.3.1      RISING DEMAND FOR ENHANCED COMPACT AND PORTABLE DEVICES            96

5.3.2      KEY FOCUS OF MARKET PLAYERS ON GEOGRAPHICAL EXPANSION              96

5.3.3      GROWING DEMAND FOR MULTIMODAL VENTILATION             97

5.3.4      RISING ADOPTION OF NON-INVASIVE VENTILATION   97

FIGURE 29         IMPACT OF INNOVATIVE SOLUTIONS  97

FIGURE 30         INTRODUCTION OF INNOVATIVE SOLUTIONS FOR SLEEP APNEA TREATMENT     98

5.4         REGULATORY ANALYSIS            98

5.4.1      REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS          98

TABLE 8             NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         98

TABLE 9             EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         98

TABLE 10           REST OF THE WORLD: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS         99

5.4.2      NORTH AMERICA          99

5.4.2.1   US         99

TABLE 11           US: CLASSIFICATION OF MEDICAL EQUIPMENT             99

TABLE 12           US: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS           100

5.4.2.2   Canada  100

TABLE 13           CANADA: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS          100

5.4.3      EUROPE             100

TABLE 14           EUROPE: LEVEL OF RISK, TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS          101

5.4.4      ASIA PACIFIC    101

5.4.4.1   Japan     101

TABLE 15           JAPAN: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS           102

5.4.4.2   China     102

TABLE 16           CHINA: TIME, COST, AND COMPLEXITY OF REGISTRATION PROCESS           102

5.4.4.3   India      103

5.5         ECOSYSTEM ANALYSIS 103

FIGURE 31         RESPIRATORY CARE DEVICES MARKET: ECOSYSTEM ANALYSIS              104

5.6         VALUE CHAIN ANALYSIS            104

FIGURE 32         RESPIRATORY CARE DEVICES MARKET: VALUE CHAIN ANALYSIS          105

5.7         IMPACT OF COVID-19 ON RESPIRATORY CARE DEVICES MARKET              105

5.8         TECHNOLOGY ANALYSIS           106

5.8.1      E-NOSE TECHNOLOGY 106

5.8.2      MEMS TECHNOLOGY   106

5.8.3      ELECTROCHEMICAL TECHNOLOGY     106

5.8.4      WIRELESS GAS SENSOR TECHNOLOGY 107

5.9         PATENT ANALYSIS        107

5.9.1      PATENT PUBLICATION TRENDS FOR RESPIRATORY CARE DEVICES              107

FIGURE 33         PATENT PUBLICATION TRENDS (2015–2023)     107

5.9.2      TOP APPLICANTS FOR RESPIRATORY CARE DEVICE PATENTS, BY GEOGRAPHY (2015–2023)           108

TABLE 17           TOP APPLICANTS FOR RESPIRATORY CARE DEVICE PATENTS, BY GEOGRAPHY            108

5.9.3      RESPIRATORY CARE DEVICES MARKET: TOP APPLICANTS         108

FIGURE 34         TOP APPLICANTS FOR RESPIRATORY CARE DEVICES PATENTS (2015–2023)       108

5.10       TRADE ANALYSIS          109

TABLE 18           TOP EXPORTERS OF MEDICAL VENTILATORS, CPAP, BIPAP, AND OXYGEN CONCENTRATORS, 2021 109

5.11       CASE STUDY ANALYSIS 110

TABLE 19           REPLACEMENT PATTERN OF VENTILATORS: DEVELOPED ECONOMIES VS. EMERGING ECONOMIES           110

TABLE 20           VOLUME DATA OF VENTILATORS, ICU VENTILATORS, PORTABLE VENTILATORS, PAP DEVICES, CPAP DEVICES, BIPAP DEVICES, AND SPIROMETERS  110

5.12       PORTER’S FIVE FORCES ANALYSIS         111

TABLE 21           PORTER’S FIVE FORCES ANALYSIS         111

5.12.1    THREAT OF NEW ENTRANTS    111

5.12.2    THREAT OF SUBSTITUTES         112

5.12.3    BARGAINING POWER OF SUPPLIERS     112

5.12.4    BARGAINING POWER OF BUYERS           112

5.12.5    INTENSITY OF COMPETITIVE RIVALRY 112

5.13       KEY CONFERENCES AND EVENTS, 2023–2024     113

5.13.1    RESPIRATORY CARE DEVICES MARKET: LIST OF KEY CONFERENCES AND EVENTS    113

5.14       KEY STAKEHOLDERS AND BUYING CRITERIA    113

5.14.1    KEY STAKEHOLDERS IN BUYING PROCESS         113

TABLE 22           STAKEHOLDERS IN BUYING PROCESS FOR RESPIRATORY CARE DEVICES 113

TABLE 23           INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR RESPIRATORY CARE DEVICES   115

5.14.2    BUYING CRITERIA         115

FIGURE 35         KEY BUYING CRITERIA FOR RESPIRATORY DEVICES      115

TABLE 24           KEY BUYING CRITERIA FOR RESPIRATORY CARE DEVICES              115

5.15       PRICING ANALYSIS        116

TABLE 25           AVERAGE SELLING PRICE OF RESPIRATORY CARE DEVICES              116

5.16       UNMET NEEDS PERTAINING TO RESPIRATORY CARE DEVICES 116

TABLE 26           RESPIRATORY CARE DEVICES MARKET: UNMET NEEDS 116

5.16.1    END USER EXPECTATIONS        117

TABLE 27           RESPIRATORY CARE DEVICES MARKET: END USER EXPECTATIONS             117

5.17       APPLICATION OF ARTIFICIAL INTELLIGENCE IN RESPIRATORY CARE DEVICES            119

TABLE 28           RESPIRATORY CARE DEVICES MARKET: APPLICATION OF ARTIFICIAL INTELLIGENCE       119

5.17.1    FUTURE OF HEALTHCARE—BIG DATA AND ARTIFICIAL INTELLIGENCE 119

5.18       REIMBURSEMENT SCENARIO    120

TABLE 29           RESPIRATORY CARE DEVICES MARKET: REIMBURSEMENT SCENARIO         120

6            RESPIRATORY CARE DEVICES MARKET, BY PRODUCT   122

6.1         INTRODUCTION            123

TABLE 30           RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)     123

TABLE 31           RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     124

6.2         THERAPEUTIC RESPIRATORY CARE DEVICES    124

TABLE 32           THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)             125

TABLE 33           THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    126

6.2.1      PAP DEVICES    126

TABLE 34           PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)              127

TABLE 35           PAP DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          127

TABLE 36           PAP DEVICES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 128

6.2.1.1   CPAP devices      128

6.2.1.1.1 Growing popularity of nasal CPAP therapies to drive demand   128

TABLE 37           MAJOR PLAYERS OFFERING CPAP DEVICES IN MARKET 129

TABLE 38           CPAP DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          129

TABLE 39           CPAP DEVICES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 130

6.2.1.2   APAP devices      130

6.2.1.2.1 Rising awareness among sleep specialists and patients regarding additional features of APAP devices to boost market      130

TABLE 40           MAJOR PLAYERS OFFERING APAP DEVICES IN MARKET 130

TABLE 41           APAP DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          131

TABLE 42           APAP DEVICES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 131

6.2.1.3   BiPAP devices     132

6.2.1.3.1 Increasing number of hospitals to strengthen market   132

TABLE 43           MAJOR PLAYERS OFFERING BIPAP DEVICES IN MARKET              132

TABLE 44           BIPAP DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          133

TABLE 45           BIPAP DEVICES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 133

6.2.2      VENTILATORS 134

TABLE 46           VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)              134

TABLE 47           VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          135

TABLE 48           VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 135

6.2.2.1   ICU ventilators    136

TABLE 49           MAJOR PLAYERS OFFERING ICU VENTILATORS IN MARKET              136

TABLE 50           ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          137

TABLE 51           ICU VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          138

TABLE 52           ICU VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)     138

6.2.2.1.1 High-end ventilators          139

6.2.2.1.1.1           Improving healthcare infrastructure and rising healthcare expenditure to drive market        139

TABLE 53           HIGH-END VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 139

TABLE 54           HIGH-END VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)     140

6.2.2.1.2 Mid-end ventilators           140

6.2.2.1.2.1           Better affordability and accessibility of mid-end ventilators than high-end models to support market growth            140

TABLE 55           MID-END VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 141

TABLE 56           MID-END VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)     141

6.2.2.1.3 Basic ventilators  142

6.2.2.1.3.1           Expanding access to critical healthcare facilities in developing countries to spur demand    142

TABLE 57           BASIC VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          142

TABLE 58           BASIC VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)     143

6.2.2.2   Portable/Transportable ventilators  143

6.2.2.2.1 Increasing demand for home care to boost segmental growth     143

TABLE 59           MAJOR PLAYERS OFFERING PORTABLE/TRANSPORTABLE VENTILATORS IN MARKET        144

TABLE 60           PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    145

TABLE 61           PORTABLE/TRANSPORTABLE VENTILATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)             146

6.2.3      NEBULIZERS     146

TABLE 62           MAJOR PLAYERS OFFERING NEBULIZERS IN MARKET    146

TABLE 63           NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)              148

TABLE 64           NEBULIZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          148

TABLE 65           NEBULIZERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 149

6.2.3.1   Jet nebulizers       149

6.2.3.1.1 Increasing prevalence of respiratory conditions to augment market size   149

TABLE 66           JET NEBULIZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          150

TABLE 67           JET NEBULIZERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 150

6.2.3.2   Mesh nebulizers   151

6.2.3.2.1 Deployment of advanced aerosolization technology to drive market         151

TABLE 68           MESH NEBULIZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          151

TABLE 69           MESH NEBULIZERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)     152

6.2.3.3   Ultrasonic nebulizers         152

6.2.3.3.1 Adjustable settings for particle size and treatment duration to boost market              152

TABLE 70           ULTRASONIC NEBULIZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 153

TABLE 71           ULTRASONIC NEBULIZERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)     153

6.2.4      HUMIDIFIERS   154

TABLE 72           HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)              154

TABLE 73           HUMIDIFIERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          155

TABLE 74           HUMIDIFIERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 155

6.2.4.1   Heated humidifiers            156

6.2.4.1.1 Ease of control and customizability to grow market      156

TABLE 75           MAJOR PLAYERS OFFERING HEATED HUMIDIFIERS IN MARKET            156

TABLE 76           HEATED HUMIDIFIERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          157

TABLE 77           HEATED HUMIDIFIERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)     158

6.2.4.2   Passover humidifiers          158

6.2.4.2.1 Minimal maintenance and simple technology to spur demand    158

TABLE 78           MAJOR PLAYERS OFFERING PASSOVER HUMIDIFIERS IN MARKET            158

TABLE 79           PASSOVER HUMIDIFIERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 159

TABLE 80           PASSOVER HUMIDIFIERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)     159

6.2.5      OXYGEN CONCENTRATORS      160

TABLE 81           MAJOR PLAYERS OFFERING OXYGEN CONCENTRATORS IN MARKET            160

TABLE 82           OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          160

TABLE 83           OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 161

TABLE 84           OXYGEN CONCENTRATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)     161

6.2.5.1   Fixed oxygen concentrators             162

6.2.5.1.1 Better access to healthcare services to grow demand    162

TABLE 85           FIXED OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          162

TABLE 86           FIXED OXYGEN CONCENTRATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)          163

6.2.5.2   Portable oxygen concentrators         163

6.2.5.2.1 Low weight and easy setup to drive segmental growth  163

TABLE 87           PORTABLE OXYGEN CONCENTRATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    164

TABLE 88           PORTABLE OXYGEN CONCENTRATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 164

6.2.6      INHALERS         165

TABLE 89           INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)              165

TABLE 90           INHALERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)              166

TABLE 91           INHALERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 166

6.2.6.1   Metered-dose inhalers (MDIs)        167

6.2.6.1.1 Ongoing advancements in MDI technology to support market growth     167

TABLE 92           METERED-DOSE INHALERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 167

TABLE 93           METERED-DOSE INHALERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)     168

6.2.6.2   Dry powder inhalers (DPIs)            168

6.2.6.2.1 Developments in particle engineering and powder formulations to boost segmental growth 168

TABLE 94           DRY POWDER INHALERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 169

TABLE 95           DRY POWDER INHALERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)     169

6.2.7      REUSABLE RESUSCITATORS      170

6.2.7.1   Disposable and reusable nature to drive demand          170

TABLE 96           MAJOR PLAYERS OFFERING REUSABLE RESUSCITATORS IN MARKET            170

TABLE 97           REUSABLE RESUSCITATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 171

TABLE 98           REUSABLE RESUSCITATORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)     171

6.2.8      NITRIC OXIDE DELIVERY UNITS             172

6.2.8.1   Rising emphasis of companies on developing innovative and advanced nitric oxide delivery units to drive market           172

TABLE 99           MAJOR PLAYERS OFFERING NITRIC OXIDE DELIVERY UNITS IN MARKET            172

TABLE 100         NITRIC OXIDE DELIVERY UNITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     173

TABLE 101         NITRIC OXIDE DELIVERY UNITS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)          173

6.2.9      OXYGEN HOODS           174

6.2.9.1   Growing prevalence of respiratory diseases in kids to drive market growth              174

TABLE 102         MAJOR PLAYERS OFFERING OXYGEN HOODS IN MARKET              174

TABLE 103         OXYGEN HOODS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          175

TABLE 104         OXYGEN HOODS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 175

6.3         MONITORING DEVICES 176

TABLE 105        RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)          176

TABLE 106         RESPIRATORY CARE MONITORING DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    177

6.3.1      PULSE OXIMETERS        177

TABLE 107         MAJOR PLAYERS OFFERING PULSE OXIMETERS IN MARKET              178

TABLE 108         PULSE OXIMETERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          178

TABLE 109         PULSE OXIMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          179

TABLE 110         PULSE OXIMETERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)     179

6.3.1.1   Pulse oximeter sensors       180

6.3.1.1.1 Development of advanced sensors with embedded chips to boost segmental growth   180

TABLE 111         PULSE OXIMETER SENSORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 180

TABLE 112         PULSE OXIMETER SENSORS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)     181

6.3.1.2   Pulse oximeter equipment 181

6.3.1.2.1 Growing prevalence of chronic respiratory conditions to boost demand   181

TABLE 113         MAJOR PLAYERS OFFERING PULSE OXIMETER EQUIPMENT IN MARKET            181

TABLE 114         PULSE OXIMETER EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     182

TABLE 115         PULSE OXIMETER EQUIPMENT MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)          182

6.3.2      CAPNOGRAPHS             183

6.3.2.1   Ongoing R&D on capnographs to offer lucrative growth opportunities    183

TABLE 116         MAJOR PLAYERS OFFERING CAPNOGRAPHS IN MARKET              183

TABLE 117         CAPNOGRAPHS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          184

TABLE 118         CAPNOGRAPHS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 184

6.3.3      GAS ANALYZERS            185

6.3.3.1   Increasing demand for point-of-care testing to drive demand     185

TABLE 119         MAJOR PLAYERS OFFERING GAS ANALYZERS IN MARKET              185

TABLE 120         GAS ANALYZERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          186

TABLE 121         GAS ANALYZERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 186

6.4         DIAGNOSTIC RESPIRATORY CARE DEVICES      187

TABLE 122         DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)          187

TABLE 123         DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    188

6.4.1      SPIROMETERS  188

6.4.1.1   Rising technological advancements in spirometers to support market growth              188

TABLE 124         MAJOR PLAYERS OFFERING SPIROMETERS IN MARKET 189

TABLE 125         SPIROMETERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          190

TABLE 126         SPIROMETERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS) 190

6.4.2      POLYSOMNOGRAPHY DEVICES (PSG DEVICES) 191

6.4.2.1   Rising incidence of obstructive sleep apnea to drive demand      191

TABLE 127         MAJOR PLAYERS OFFERING POLYSOMNOGRAPHY DEVICES IN MARKET            191

TABLE 128         POLYSOMNOGRAPHY DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     192

TABLE 129         POLYSOMNOGRAPHY DEVICES MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)          192

6.4.3      PEAK FLOW METERS     193

6.4.3.1   Low-cost and uncomplicated nature to drive segmental growth  193

TABLE 130         MAJOR PLAYERS OFFERING PEAK FLOW METERS IN MARKET              193

TABLE 131         PEAK FLOW METERS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          194

TABLE 132         PEAK FLOW METERS MARKET, BY REGION, 2021–2028 (THOUSAND UNITS)     194

6.4.4      OTHER DIAGNOSTIC DEVICES 195

TABLE 133         OTHER DIAGNOSTIC DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     195

6.5         CONSUMABLES & ACCESSORIES             196

TABLE 134         RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)       196

TABLE 135         RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)            197

6.5.1      MASKS 197

TABLE 136         MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)    198

TABLE 137         MASKS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)              198

6.5.1.1   Reusable masks    199

6.5.1.1.1 Growing concerns related to air pollution to grow demand         199

TABLE 138         REUSABLE MASKS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          199

6.5.1.2   Disposable masks 200

6.5.1.2.1 Stringent government mandates on wearing masks to spur demand         200

TABLE 139         DISPOSABLE MASKS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          200

6.5.2      DISPOSABLE RESUSCITATORS  201

6.5.2.1   Growing focus on reducing cross-contamination cases in patients to foster segmental growth 201

TABLE 140         DISPOSABLE RESUSCITATORS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)     201

6.5.3      TRACHEOSTOMY TUBES           202

6.5.3.1   Introduction of new and advanced products with ergonomic designs to drive market growth     202

TABLE 141         TRACHEOSTOMY TUBES MARKET, BY COUNTRY, 2021–2028 (USD MILLION) 202

6.5.4      BREATHING CIRCUITS  203

6.5.4.1   Healthcare professionals’ efforts to improve infection control practices to grow demand 203

TABLE 142         BREATHING CIRCUITS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          203

6.5.5      NASAL CANNULAE        204

6.5.5.1   Increasing focus on minimally invasive surgery techniques to fuel demand              204

TABLE 143         NASAL CANNULAE MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          204

6.5.6      OTHER CONSUMABLES & ACCESSORIES             205

TABLE 144         OTHER CONSUMABLES & ACCESSORIES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    205

7            RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION              206

7.1         INTRODUCTION            207

TABLE 145         RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)             207

7.2         CHRONIC OBSTRUCTIVE PULMONARY DISEASE (COPD)            207

7.2.1      RISING INDOOR AND OUTDOOR AIR POLLUTION LEVELS TO DRIVE MARKET            207

TABLE 146         RESPIRATORY CARE DEVICES MARKET FOR COPD, BY COUNTRY, 2021–2028 (USD MILLION)    208

7.3         SLEEP APNEA   209

7.3.1      GROWING INCIDENCE OF OBESITY AND CARDIOVASCULAR DISEASES TO FAVOR MARKET GROWTH  209

TABLE 147         COUNTRY-WISE DATA ON SLEEP APNEA PATIENTS      209

TABLE 148         RESPIRATORY CARE DEVICES MARKET FOR SLEEP APNEA, BY COUNTRY, 2021–2028 (USD MILLION)    210

7.4         ASTHMA            211

7.4.1      INCREASING INCIDENCE OF COPD TO DRIVE MARKET 211

TABLE 149         RESPIRATORY CARE DEVICES MARKET FOR ASTHMA, BY COUNTRY, 2021–2028 (USD MILLION)    211

7.5         INFECTIOUS DISEASES 212

7.5.1      GROWING NUMBER OF TB PATIENTS TO BOOST MARKET GROWTH              212

TABLE 150         INCIDENCE OF TB (RATE PER 100,000 POPULATION)    212

TABLE 151         RESPIRATORY CARE DEVICES MARKET FOR INFECTIOUS DISEASES, BY COUNTRY, 2021–2028 (USD MILLION)       213

7.6         OTHER DISEASE INDICATIONS 213

TABLE 152         RESPIRATORY CARE DEVICES MARKET FOR OTHER DISEASE INDICATIONS, BY COUNTRY, 2021–2028 (USD MILLION)             214

8            RESPIRATORY CARE DEVICES MARKET, BY END USER   215

8.1         INTRODUCTION            216

TABLE 153         RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)     216

8.2         HOSPITALS       216

8.2.1      GROWING NUMBER OF HOSPITALS IN EMERGING ECONOMIES TO DRIVE MARKET 216

TABLE 154         RESPIRATORY CARE DEVICES MARKET FOR HOSPITALS, BY COUNTRY, 2021–2028 (USD MILLION)    217

8.3         HOME CARE SETTINGS 218

8.3.1      INCREASING ACCEPTANCE OF HOME CARE DEVICES BY PATIENTS TO BOOST GROWTH           218

TABLE 155         RESPIRATORY CARE DEVICES MARKET FOR HOME CARE SETTINGS, BY COUNTRY, 2021–2028 (USD MILLION)      219

8.4         AMBULATORY CARE CENTERS (ACCS)  219

8.4.1      IMPROVED PATIENT EXPERIENCE IN AMBULATORY CARE CENTERS TO DRIVE MARKET       219

TABLE 156         RESPIRATORY CARE DEVICES MARKET FOR AMBULATORY CARE CENTERS, BY COUNTRY, 2021–2028 (USD MILLION)           220

8.5         OTHER END USERS        221

TABLE 157         RESPIRATORY CARE DEVICES MARKET FOR OTHER END USERS, BY COUNTRY, 2021–2028 (USD MILLION)             221

9            RESPIRATORY CARE DEVICES MARKET, BY REGION       222

9.1         INTRODUCTION            223

FIGURE 36         RESPIRATORY CARE DEVICES MARKET: REGIONAL GROWTH OPPORTUNITIES           223

TABLE 158         RESPIRATORY CARE DEVICES MARKET, BY REGION, 2021–2028 (USD MILLION) 224

9.2         NORTH AMERICA          225

FIGURE 37         NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET SNAPSHOT        225

TABLE 159         NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    226

TABLE 160         NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   226

TABLE 161         NORTH AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 227

TABLE 162         NORTH AMERICA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 227

TABLE 163         NORTH AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)             227

TABLE 164         NORTH AMERICA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 228

TABLE 165         NORTH AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)     228

TABLE 166         NORTH AMERICA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 228

TABLE 167         NORTH AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 229

TABLE 168         NORTH AMERICA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 229

TABLE 169         NORTH AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 229

TABLE 170         NORTH AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          230

TABLE 171         NORTH AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)    230

TABLE 172         NORTH AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)      230

TABLE 173         NORTH AMERICA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)          231

TABLE 174         NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)           231

TABLE 175         NORTH AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)    231

9.2.1      NORTH AMERICA: RECESSION IMPACT 232

9.2.2      US         232

9.2.2.1   Rapid growth in geriatric population to boost market   232

TABLE 176         US: KEY MACROINDICATORS    233

TABLE 177         US: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          233

TABLE 178         US: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)             234

TABLE 179         US: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)              234

TABLE 180         US: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 234

TABLE 181         US: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          235

TABLE 182         US: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          235

TABLE 183         US: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)              235

TABLE 184         US: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)              236

TABLE 185         US: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)              236

TABLE 186         US: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)             236

TABLE 187         US: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          237

TABLE 188         US: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)             237

TABLE 189         US: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    237

TABLE 190         US: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)              238

TABLE 191         US: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)             238

TABLE 192         US: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)          238

9.2.3      CANADA            239

9.2.3.1   Large pool of undiagnosed patients to drive market     239

TABLE 193         CANADA: COPD AND ASTHMA STATISTICS (2019 VS. 2020)              239

TABLE 194         CANADA: KEY MACROINDICATORS       239

TABLE 195         CANADA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   240

TABLE 196         CANADA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)    240

TABLE 197         CANADA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)          241

TABLE 198         CANADA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)     241

TABLE 199         CANADA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          241

TABLE 200         CANADA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 242

TABLE 201         CANADA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          242

TABLE 202         CANADA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          242

TABLE 203         CANADA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          243

TABLE 204         CANADA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)    243

TABLE 205         CANADA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)     243

TABLE 206        CANADA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)       244

TABLE 207         CANADA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    244

TABLE 208         CANADA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)              244

TABLE 209         CANADA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)             245

TABLE 210         CANADA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)             245

9.3         EUROPE             245

TABLE 211        EUROPE: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)          246

TABLE 212        EUROPE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          246

TABLE 213         EUROPE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)    247

TABLE 214         EUROPE: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)          247

TABLE 215         EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)     247

TABLE 216         EUROPE: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          248

TABLE 217         EUROPE: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 248

TABLE 218         EUROPE: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          248

TABLE 219         EUROPE: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          249

TABLE 220         EUROPE: NEBULIZER MARKET, BY TYPE, 2021–2028 (USD MILLION)          249

TABLE 221         EUROPE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)    249

TABLE 222         EUROPE: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 250

TABLE 223         EUROPE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)       250

TABLE 224         EUROPE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    250

TABLE 225         EUROPE: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)              251

TABLE 226         EUROPE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)             251

TABLE 227        EUROPE: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)          251

9.3.1      EUROPE: RECESSION IMPACT   252

9.3.2      GERMANY         252

9.3.2.1   Increasing public healthcare expenditure to foster market growth            252

TABLE 228         GERMANY: KEY MACROINDICATORS    252

TABLE 229         GERMANY: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   253

TABLE 230         GERMANY: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)    253

TABLE 231         GERMANY: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)          254

TABLE 232         GERMANY: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          254

TABLE 233         GERMANY: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          254

TABLE 234         GERMANY: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 255

TABLE 235         GERMANY: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          255

TABLE 236         GERMANY: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          255

TABLE 237         GERMANY: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          256

TABLE 238         GERMANY: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)    256

TABLE 239         GERMANY: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)     256

TABLE 240         GERMANY: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)    257

TABLE 241         GERMANY: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)      257

TABLE 242         GERMANY: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)          257

TABLE 243         GERMANY: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)             258

TABLE 244         GERMANY: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)             258

9.3.3      FRANCE             258

9.3.3.1   High prevalence of COPD to surge demand   258

TABLE 245         FRANCE: KEY MACROINDICATORS        259

TABLE 246        FRANCE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          259

TABLE 247         FRANCE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)    260

TABLE 248         FRANCE: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)          260

TABLE 249         FRANCE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)     260

TABLE 250         FRANCE: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          261

TABLE 251         FRANCE: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 261

TABLE 252         FRANCE: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          261

TABLE 253         FRANCE: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          261

TABLE 254         FRANCE: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          262

TABLE 255        FRANCE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)       262

TABLE 256         FRANCE: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 262

TABLE 257         FRANCE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)       263

TABLE 258         FRANCE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    263

TABLE 259         FRANCE: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)              263

TABLE 260         FRANCE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)             264

TABLE 261         FRANCE: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)          264

9.3.4      UK         264

9.3.4.1   Growing demand for minimally invasive surgeries to drive market           264

TABLE 262         UK: KEY MACROINDICATORS   265

TABLE 263         UK: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          265

TABLE 264         UK: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)             266

TABLE 265         UK: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)              266

TABLE 266         UK: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 266

TABLE 267         UK: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          267

TABLE 268         UK: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          267

TABLE 269         UK: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)              267

TABLE 270         UK: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          268

TABLE 271         UK: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)              268

TABLE 272         UK: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)             268

TABLE 273         UK: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 269

TABLE 274         UK: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)             269

TABLE 275         UK: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    269

TABLE 276         UK: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)              270

TABLE 277         UK: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)             270

TABLE 278         UK: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)          270

9.3.5      ITALY   271

9.3.5.1   Growing involvement of private sector in healthcare market to drive market              271

TABLE 279         ITALY: KEY MACROINDICATORS            271

TABLE 280         ITALY: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          272

TABLE 281         ITALY: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)       272

TABLE 282         ITALY: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)          273

TABLE 283         ITALY: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)     273

TABLE 284         ITALY: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          273

TABLE 285         ITALY: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          273

TABLE 286         ITALY: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)              274

TABLE 287         ITALY: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          274

TABLE 288         ITALY: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          274

TABLE 289         ITALY: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)       275

TABLE 290         ITALY: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 275

TABLE 291         ITALY: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)       275

TABLE 292         ITALY: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    276

TABLE 293         ITALY: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)              276

TABLE 294         ITALY: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)             276

TABLE 295         ITALY: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)          277

9.3.6      SPAIN   277

9.3.6.1   Need to improve healthcare infrastructure due to aging demographic to drive demand 277

TABLE 296         SPAIN: KEY MACROINDICATORS            278

TABLE 297         SPAIN: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          278

TABLE 298         SPAIN: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)       279

TABLE 299         SPAIN: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)          279

TABLE 300         SPAIN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)     279

TABLE 301         SPAIN: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          280

TABLE 302         SPAIN: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          280

TABLE 303         SPAIN: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)              280

TABLE 304         SPAIN: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          280

TABLE 305         SPAIN: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          281

TABLE 306         SPAIN: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)       281

TABLE 307         SPAIN: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 281

TABLE 308         SPAIN: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)       282

TABLE 309         SPAIN: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    282

TABLE 310         SPAIN: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)              282

TABLE 311         SPAIN: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)             283

TABLE 312         SPAIN: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)          283

9.3.7      REST OF EUROPE           283

TABLE 313         REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   284

TABLE 314         REST OF EUROPE: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 284

TABLE 315         REST OF EUROPE: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 285

TABLE 316         REST OF EUROPE: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)             285

TABLE 317         REST OF EUROPE: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 285

TABLE 318         REST OF EUROPE: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)     286

TABLE 319         REST OF EUROPE: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 286

TABLE 320         REST OF EUROPE: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 286

TABLE 321         REST OF EUROPE: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 286

TABLE 322         REST OF EUROPE: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)    287

TABLE 323         REST OF EUROPE: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          287

TABLE 324         REST OF EUROPE: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)    287

TABLE 325         REST OF EUROPE: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)      288

TABLE 326         REST OF EUROPE: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)          288

TABLE 327         REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)           288

TABLE 328         REST OF EUROPE: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)    289

9.4         ASIA PACIFIC    289

FIGURE 38         ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET SNAPSHOT        290

TABLE 329         ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    291

TABLE 330         ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   291

TABLE 331         ASIA PACIFIC: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)    292

TABLE 332         ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)          292

TABLE 333         ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          292

TABLE 334         ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 293

TABLE 335         ASIA PACIFIC: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 293

TABLE 336         ASIA PACIFIC: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          293

TABLE 337         ASIA PACIFIC: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          293

TABLE 338         ASIA PACIFIC: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          294

TABLE 339         ASIA PACIFIC: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)    294

TABLE 340         ASIA PACIFIC: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          294

TABLE 341         ASIA PACIFIC: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)    295

TABLE 342         ASIA PACIFIC: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)      295

TABLE 343         ASIA PACIFIC: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)          295

TABLE 344         ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)           296

TABLE 345         ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)             296

9.4.1      ASIA PACIFIC: RECESSION IMPACT        296

9.4.2      JAPAN  297

9.4.2.1   Availability of universal healthcare reimbursement policy to drive market 297

TABLE 346         JAPAN: KEY MACROINDICATORS           297

TABLE 347         JAPAN: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          298

TABLE 348         JAPAN: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)       298

TABLE 349         JAPAN: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)          299

TABLE 350         JAPAN: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)     299

TABLE 351         JAPAN: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          299

TABLE 352         JAPAN: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          300

TABLE 353         JAPAN: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          300

TABLE 354         JAPAN: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          300

TABLE 355         JAPAN: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          301

TABLE 356         JAPAN: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)       301

TABLE 357         JAPAN: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 301

TABLE 358         JAPAN: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)       302

TABLE 359         JAPAN: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    302

TABLE 360         JAPAN: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)              302

TABLE 361         JAPAN: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)             303

TABLE 362         JAPAN: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)          303

9.4.3      CHINA  303

9.4.3.1   Initiatives to modernize healthcare system and reimbursement facilities to support market growth     303

TABLE 363         CHINA: KEY MACROINDICATORS           304

TABLE 364         CHINA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          304

TABLE 365         CHINA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)       305

TABLE 366         CHINA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)          305

TABLE 367         CHINA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)     305

TABLE 368         CHINA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          306

TABLE 369         CHINA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          306

TABLE 370         CHINA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          306

TABLE 371         CHINA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          306

TABLE 372         CHINA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          307

TABLE 373         CHINA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)       307

TABLE 374         CHINA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 307

TABLE 375         CHINA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)       308

TABLE 376         CHINA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    308

TABLE 377         CHINA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)              308

TABLE 378         CHINA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)             309

TABLE 379         CHINA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)          309

9.4.4      INDIA   309

9.4.4.1   Increasing focus of global players on domestic market to drive market     309

TABLE 380         INDIA: KEY MACROINDICATORS            310

TABLE 381         INDIA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          310

TABLE 382         INDIA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)       311

TABLE 383         INDIA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)          311

TABLE 384         INDIA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)     311

TABLE 385         INDIA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          312

TABLE 386         INDIA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          312

TABLE 387         INDIA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)              312

TABLE 388         INDIA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          312

TABLE 389         INDIA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          313

TABLE 390         INDIA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)       313

TABLE 391         INDIA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 313

TABLE 392         INDIA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)       314

TABLE 393         INDIA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    314

TABLE 394         INDIA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)              314

TABLE 395         INDIA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)             315

TABLE 396         INDIA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)          315

9.4.5      AUSTRALIA       315

9.4.5.1   High prevalence of chronic lung diseases to drive demand         315

TABLE 397         AUSTRALIA: KEY MACROINDICATORS  316

TABLE 398         AUSTRALIA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   316

TABLE 399         AUSTRALIA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)    317

TABLE 400         AUSTRALIA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)          317

TABLE 401         AUSTRALIA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          317

TABLE 402         AUSTRALIA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          318

TABLE 403         AUSTRALIA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 318

TABLE 404         AUSTRALIA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          318

TABLE 405         AUSTRALIA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          318

TABLE 406         AUSTRALIA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          319

TABLE 407         AUSTRALIA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)    319

TABLE 408         AUSTRALIA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)     319

TABLE 409         AUSTRALIA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)    320

TABLE 410         AUSTRALIA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)      320

TABLE 411         AUSTRALIA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)          320

TABLE 412         AUSTRALIA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)           321

TABLE 413         AUSTRALIA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)             321

9.4.6      SOUTH KOREA 321

9.4.6.1   Expanding geriatric population to fuel market 321

TABLE 414         SOUTH KOREA: KEY MACROINDICATORS          322

TABLE 415         SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   322

TABLE 416         SOUTH KOREA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)    322

TABLE 417         SOUTH KOREA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 323

TABLE 418        SOUTH KOREA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          323

TABLE 419         SOUTH KOREA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 323

TABLE 420         SOUTH KOREA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)     323

TABLE 421         SOUTH KOREA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          324

TABLE 422         SOUTH KOREA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 324

TABLE 423         SOUTH KOREA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 324

TABLE 424         SOUTH KOREA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)    325

TABLE 425         SOUTH KOREA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          325

TABLE 426         SOUTH KOREA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)    325

TABLE 427         SOUTH KOREA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)      326

TABLE 428         SOUTH KOREA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)          326

TABLE 429         SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)           327

TABLE 430         SOUTH KOREA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)    327

9.4.7      REST OF ASIA PACIFIC  327

TABLE 431         REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)            328

TABLE 432         REST OF ASIA PACIFIC: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 328

TABLE 433         REST OF ASIA PACIFIC: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)     329

TABLE 434         REST OF ASIA PACIFIC: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)       329

TABLE 435         REST OF ASIA PACIFIC: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)     329

TABLE 436         REST OF ASIA PACIFIC: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          329

TABLE 437         REST OF ASIA PACIFIC: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 330

TABLE 438         REST OF ASIA PACIFIC: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)     330

TABLE 439         REST OF ASIA PACIFIC: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)     330

TABLE 440         REST OF ASIA PACIFIC: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 331

TABLE 441         REST OF ASIA PACIFIC: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   331

TABLE 442         REST OF ASIA PACIFIC: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 331

TABLE 443         REST OF ASIA PACIFIC: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)      332

TABLE 444         REST OF ASIA PACIFIC: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 332

TABLE 445         REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)      332

TABLE 446         REST OF ASIA PACIFIC: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)            333

9.5         LATIN AMERICA             333

TABLE 447         LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)    333

TABLE 448         LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   334

TABLE 449         LATIN AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)    334

TABLE 450         LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 335

TABLE 451         LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)             335

TABLE 452         LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 335

TABLE 453         LATIN AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)     336

TABLE 454         LATIN AMERICA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          336

TABLE 455         LATIN AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 336

TABLE 456         LATIN AMERICA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION) 336

TABLE 457         LATIN AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)    337

TABLE 458         LATIN AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          337

TABLE 459         LATIN AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)    337

TABLE 460         LATIN AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)      338

TABLE 461         LATIN AMERICA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)          338

TABLE 462         LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)           338

TABLE 463         LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)    339

9.5.1      LATIN AMERICA: RECESSION IMPACT   339

9.5.2      BRAZIL 339

9.5.2.1   Government initiatives to improve healthcare sector to drive market        339

TABLE 464         BRAZIL: KEY MACROINDICATORS          340

TABLE 465         BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          340

TABLE 466        BRAZIL: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)       341

TABLE 467         BRAZIL: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)          341

TABLE 468         BRAZIL: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)     341

TABLE 469         BRAZIL: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          342

TABLE 470         BRAZIL: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          342

TABLE 471         BRAZIL: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          342

TABLE 472         BRAZIL: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          342

TABLE 473         BRAZIL: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          343

TABLE 474         BRAZIL: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)       343

TABLE 475         BRAZIL: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 343

TABLE 476         BRAZIL: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)       344

TABLE 477         BRAZIL: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    344

TABLE 478         BRAZIL: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)              344

TABLE 479         BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)             345

TABLE 480         BRAZIL: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)          345

9.5.3      MEXICO             345

9.5.3.1   Rising obesity rate to increase incidence of respiratory diseases 345

TABLE 481         MEXICO: KEY MACROINDICATORS        346

TABLE 482        MEXICO: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)          346

TABLE 483         MEXICO: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)    347

TABLE 484         MEXICO: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)          347

TABLE 485         MEXICO: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)     347

TABLE 486         MEXICO: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          348

TABLE 487         MEXICO: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION) 348

TABLE 488         MEXICO: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          348

TABLE 489         MEXICO: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          348

TABLE 490         MEXICO: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          349

TABLE 491        MEXICO: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)       349

TABLE 492         MEXICO: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION) 349

TABLE 493         MEXICO: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)       350

TABLE 494         MEXICO: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)    350

TABLE 495         MEXICO: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION)              350

TABLE 496         MEXICO: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)             351

TABLE 497        MEXICO: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)          351

9.5.4      REST OF LATIN AMERICA          351

TABLE 498         REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)        352

TABLE 499         REST OF LATIN AMERICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 352

TABLE 500         REST OF LATIN AMERICA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)          353

TABLE 501         REST OF LATIN AMERICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)    353

TABLE 502         REST OF LATIN AMERICA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          353

TABLE 503         REST OF LATIN AMERICA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)             354

TABLE 504         REST OF LATIN AMERICA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)     354

TABLE 505         REST OF LATIN AMERICA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          354

TABLE 506         REST OF LATIN AMERICA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          355

TABLE 507         REST OF LATIN AMERICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 355

TABLE 508         REST OF LATIN AMERICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   355

TABLE 509         REST OF LATIN AMERICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 356

TABLE 510         REST OF LATIN AMERICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)   356

TABLE 511         REST OF LATIN AMERICA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 356

TABLE 512         REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)  357

TABLE 513         REST OF LATIN AMERICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)         357

9.6         MIDDLE EAST & AFRICA             357

9.6.1      PRESENCE OF UNSATURATED MARKETS TO OFFER LUCRATIVE GROWTH OPPORTUNITIES TO PLAYERS            357

TABLE 514         MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY PRODUCT, 2021–2028 (USD MILLION)        358

TABLE 515         MIDDLE EAST & AFRICA: THERAPEUTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 358

TABLE 516         MIDDLE EAST & AFRICA: PAP DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION)          359

TABLE 517         MIDDLE EAST & AFRICA: OXYGEN CONCENTRATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)       359

TABLE 518         MIDDLE EAST & AFRICA: VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          359

TABLE 519        MIDDLE EAST & AFRICA: ICU VENTILATORS MARKET, BY TYPE, 2021–2028 (USD MILLION)          359

TABLE 520         MIDDLE EAST & AFRICA: INHALERS MARKET, BY TYPE, 2021–2028 (USD MILLION)     360

TABLE 521         MIDDLE EAST & AFRICA: HUMIDIFIERS MARKET, BY TYPE, 2021–2028 (USD MILLION)          360

TABLE 522         MIDDLE EAST & AFRICA: NEBULIZERS MARKET, BY TYPE, 2021–2028 (USD MILLION)     360

TABLE 523         MIDDLE EAST & AFRICA: RESPIRATORY CARE MONITORING DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 361

TABLE 524         MIDDLE EAST & AFRICA: PULSE OXIMETERS MARKET, BY PRODUCT, 2021–2028 (USD MILLION)   361

TABLE 525         MIDDLE EAST & AFRICA: DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET, BY TYPE, 2021–2028 (USD MILLION) 361

TABLE 526         MIDDLE EAST & AFRICA: RESPIRATORY CARE CONSUMABLES & ACCESSORIES MARKET, BY TYPE, 2021–2028 (USD MILLION)   362

TABLE 527         MIDDLE EAST & AFRICA: MASKS MARKET, BY TYPE, 2021–2028 (USD MILLION) 362

TABLE 528         MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY DISEASE INDICATION, 2021–2028 (USD MILLION)  362

TABLE 529         MIDDLE EAST & AFRICA: RESPIRATORY CARE DEVICES MARKET, BY END USER, 2021–2028 (USD MILLION)         363

9.6.2      MIDDLE EAST & AFRICA: RECESSION IMPACT   363

10          COMPETITIVE LANDSCAPE       364

10.1       INTRODUCTION            364

10.2       RIGHT TO WIN/KEY STRATEGIES           364

10.3       STRATEGIES ADOPTED BY KEY PLAYERS           365

10.4       REVENUE ANALYSIS FOR TOP FIVE MARKET PLAYERS  366

FIGURE 39         REVENUE ANALYSIS OF TOP FIVE PLAYERS IN RESPIRATORY CARE DEVICES MARKET             366

10.5       MARKET SHARE ANALYSIS         366

FIGURE 40         RESPIRATORY CARE DEVICES MARKET SHARE, BY KEY PLAYER (2022)   367

FIGURE 41         SHARE OF LEADING COMPANIES IN GLOBAL THERAPEUTIC RESPIRATORY CARE DEVICES MARKET (2022)   367

FIGURE 42         SHARE OF LEADING COMPANIES IN GLOBAL MONITORING DEVICES MARKET (2022)            368

FIGURE 43         SHARE OF LEADING COMPANIES IN GLOBAL DIAGNOSTIC RESPIRATORY CARE DEVICES MARKET (2022)   368

10.6       COMPANY EVALUATION MATRIX          369

10.6.1    STARS  369

10.6.2    EMERGING LEADERS    369

10.6.3    PERVASIVE PLAYERS     369

10.6.4    PARTICIPANTS 370

FIGURE 44         RESPIRATORY CARE DEVICES MARKET: COMPETITIVE LEADERSHIP MATRIX, 2022        370

10.7       COMPANY EVALUATION MATRIX FOR SMES/START-UPS (2022) 371

10.7.1    PROGRESSIVE COMPANIES       371

10.7.2    DYNAMIC COMPANIES 371

10.7.3    STARTING BLOCKS       371

10.7.4    RESPONSIVE COMPANIES          371

FIGURE 45         RESPIRATORY CARE DEVICES MARKET: COMPANY EVALUATION MATRIX FOR SMES/START-UPS, 2022       372

10.8       COMPETITIVE BENCHMARKING            373

TABLE 530         RESPIRATORY CARE DEVICES MARKET: KEY STARTUPS/SMES              373

10.8.1    COMPANY FOOTPRINT 374

TABLE 531         FOOTPRINT OF COMPANIES, BY OFFERING (25 COMPANIES)              374

TABLE 532         FOOTPRINT OF COMPANIES, BY DISEASE INDICATION (25 COMPANIES)    375

TABLE 533         FOOTPRINT OF COMPANIES, BY END USER (25 COMPANIES)              377

FIGURE 46         OVERALL FOOTPRINT OF COMPANIES (25 COMPANIES)              378

10.8.2    COMPETITIVE SCENARIOS AND TRENDS           378

10.8.3    PRODUCT LAUNCHES  379

TABLE 534         RESPIRATORY CARE DEVICES MARKET: PRODUCT LAUNCHES (2019–2023)       379

10.8.4    DEALS  379

TABLE 535         RESPIRATORY CARE DEVICES MARKET: DEALS (2019–2023)              379

11          COMPANY PROFILES    381

11.1       KEY PLAYERS   381

(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*

11.1.1    KONINKLIJKE PHILIPS N.V.        381

TABLE 536         KONINKLIJKE PHILIPS N.V.: BUSINESS OVERVIEW          381

FIGURE 47         KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT (2022)              382

11.1.2    MEDTRONIC     386

TABLE 537         MEDTRONIC: BUSINESS OVERVIEW       386

FIGURE 48         MEDTRONIC: COMPANY SNAPSHOT (2022)       387

11.1.3    RESMED            391

TABLE 538         RESMED: BUSINESS OVERVIEW 391

FIGURE 49         RESMED: COMPANY SNAPSHOT (2022) 392

11.1.4    MASIMO            398

TABLE 539         MASIMO: BUSINESS OVERVIEW 398

FIGURE 50         MASIMO: COMPANY SNAPSHOT (2022) 399

11.1.5    FISHER & PAYKEL HEALTHCARE LIMITED         404

TABLE 540         FISHER & PAYKEL HEALTHCARE LIMITED: BUSINESS OVERVIEW        404

FIGURE 51         FISHER & PAYKEL HEALTHCARE LIMITED: COMPANY SNAPSHOT (2022)          405

11.1.6    DRÄGERWERK AG & CO. KGAA 409

TABLE 541         DRÄGERWERK AG & CO. KGAA: BUSINESS OVERVIEW   409

FIGURE 52         DRÄGERWERK AG & CO. KGAA: COMPANY SNAPSHOT (2022)              409

11.1.7    GETINGE           412

TABLE 542         GETINGE: BUSINESS OVERVIEW             412

FIGURE 53         GETINGE: COMPANY SNAPSHOT (2022) 413

11.1.8    NIHON KOHDEN CORPORATION           415

TABLE 543         NIHON KOHDEN CORPORATION: BUSINESS OVERVIEW              415

FIGURE 54         NIHON KOHDEN CORPORATION: COMPANY SNAPSHOT (2022)              415

11.1.9    GE HEALTHCARE          418

TABLE 544         GE HEALTHCARE: BUSINESS OVERVIEW             418

FIGURE 55         GE HEALTHCARE: COMPANY SNAPSHOT (2022)             418

11.1.10  VYAIRE MEDICAL, INC. 420

TABLE 545         VYAIRE MEDICAL, INC.: BUSINESS OVERVIEW   420

11.1.11  BAXTER INTERNATIONAL, INC. 424

TABLE 546         BAXTER INTERNATIONAL, INC.: BUSINESS OVERVIEW  424

FIGURE 56         BAXTER INTERNATIONAL, INC.: COMPANY SNAPSHOT (2022)              425

11.1.12  ADAPTHEALTH, LLC    428

TABLE 547         ADAPTHEALTH, LLC: BUSINESS OVERVIEW       428

FIGURE 57         ADAPTHEALTH, LLC: COMPANY SNAPSHOT (2022)       428

11.1.13  ROTECH HEALTHCARE, INC.     430

TABLE 548         ROTECH HEALTHCARE INC.: BUSINESS OVERVIEW        430

11.1.14  TELEFLEX INCORPORATED      431

TABLE 549         TELEFLEX INCORPORATED: BUSINESS OVERVIEW         431

FIGURE 58         TELEFLEX INCORPORATED: COMPANY SNAPSHOT (2022)              432

11.1.15  AIR LIQUIDE     434

TABLE 550         AIR LIQUIDE: BUSINESS OVERVIEW       434

FIGURE 59         AIR LIQUIDE: COMPANY SNAPSHOT (2022)        435

11.2       OTHER PLAYERS           438

11.2.1    INVACARE CORPORATION        438

TABLE 551         INVACARE CORPORATION: BUSINESS OVERVIEW          438

FIGURE 60         INVACARE CORPORATION: COMPANY SNAPSHOT (2022)              439

11.2.2    ICU MEDICAL   441

TABLE 552         ICU MEDICAL: BUSINESS OVERVIEW     441

FIGURE 61         ICU MEDICAL: COMPANY SNAPSHOT (2022)      442

11.2.3    HAMILTON MEDICAL AG           444

TABLE 553         HAMILTON MEDICAL AG: BUSINESS OVERVIEW             444

11.2.4    APEX MEDICAL CORP   447

TABLE 554         APEX MEDICAL CORP: BUSINESS OVERVIEW     447

11.2.5    MEDLINE INDUSTRIES, LP         449

TABLE 555         MEDLINE INDUSTRIES, LP: BUSINESS OVERVIEW           449

11.2.6    HUM SOCIETY FOR HOMECARE AND MEDICAL TECHNOLOGY MBH              452

TABLE 556         HUM SOCIETY FOR HOMECARE AND MEDICAL TECHNOLOGY MBH: BUSINESS OVERVIEW       452

11.2.7    NONIN 454

11.2.8    ALLIED MEDICAL LLC  455

11.2.9    DRIVE DEVILBISS HEALTHCARE             456

11.2.10  OMRON HEALTHCARE, INC.      457

*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.

12          APPENDIX         458

12.1       DISCUSSION GUIDE      458

12.2       KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL             465

12.3       CUSTOMIZATION OPTIONS      467

12.4       RELATED REPORTS       467

12.5       AUTHOR DETAILS         468